Michael H. Pillinger

16.9k total citations · 3 hit papers
191 papers, 9.2k citations indexed

About

Michael H. Pillinger is a scholar working on Nephrology, Rheumatology and Surgery. According to data from OpenAlex, Michael H. Pillinger has authored 191 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Nephrology, 69 papers in Rheumatology and 59 papers in Surgery. Recurrent topics in Michael H. Pillinger's work include Gout, Hyperuricemia, Uric Acid (89 papers), Case Reports on Hematomas (33 papers) and Inflammasome and immune disorders (25 papers). Michael H. Pillinger is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (89 papers), Case Reports on Hematomas (33 papers) and Inflammasome and immune disorders (25 papers). Michael H. Pillinger collaborates with scholars based in United States, Switzerland and Sweden. Michael H. Pillinger's co-authors include Steven B. Abramson, José U. Scher, Jean Y. Park, Svetlana Krasnokutsky, Aryeh M. Abeles, Binita Shah, Chio Yokose, Adam Mor, Hyon K. Choi and K. Sharan and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michael H. Pillinger

184 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007–2016

2019 702 citations Michael H. Pillinger et al. Arthritis & Rheumatology profile →
Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases

2006 588 citations Jean Y. Park, Michael H. Pillinger et al. profile →
Periodontal disease and the oral microbiota in new‐onset rheumatoid arthritis

2012 351 citations Mukundan Attur, Michael H. Pillinger et al. profile →

Peers

Countries citing papers authored by Michael H. Pillinger

Since Specialization

Citations

This map shows the geographic impact of Michael H. Pillinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Pillinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Pillinger more than expected).

Fields of papers citing papers by Michael H. Pillinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Pillinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Pillinger. The network helps show where Michael H. Pillinger may publish in the future.

Co-authorship network of co-authors of Michael H. Pillinger

This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Pillinger. A scholar is included among the top collaborators of Michael H. Pillinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Pillinger. Michael H. Pillinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of Gout Flares With the Initiation of Treat‐to‐Target Allopurinol and Febuxostat: A Post‐Hoc Analysis of a Randomized Multicenter Trial 2024 ·Arthritis & Rheumatology ·(unknown), (unknown), Maria Androsenko, (unknown), Bridget Kramer, (unknown), Mary T. Brophy, Anne Davis‐Karim, Bryant R. England, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, Tony R. Merriman, James R. O’Dell, Ted R. Mikuls	1
2	Arthrocentesis and soft tissue aspiration and injection 2023 ·Best Practice & Research Clinical Rheumatology ·Michael Toprover, (unknown), Michael H. Pillinger	0
3	Accuracy of Financial Disclosures in US‐Based Rheumatology Journals 2023 ·Arthritis Care & Research ·(unknown), Michael H. Pillinger, Aryeh M. Abeles	2
4	Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout 2023 ·Arthritis & Rheumatology ·(unknown), James R. O’Dell, (unknown), Maria Androsenko, Mary T. Brophy, Anne Davis‐Karim, Bryant R. England, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, (unknown), Bridget Kramer, Ted R. Mikuls	8
5	Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout 2023 ·Current Rheumatology Reports ·(unknown), (unknown), Jay Pendse, Michael Toprover, Michael H. Pillinger	4
6	Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease 2021 ·The American Journal of Medicine ·Philip C. Robinson, Robert Terkeltaub, Michael H. Pillinger, Binita Shah, Vangelis Karalis, Eleni Karatza, David Liew, Massimo Imazio, Jan H. Cornel, Peter L. Thompson, Mark Nidorf	68
7	Dapansutrile: a new hope? 2020 ·The Lancet Rheumatology ·Michael Toprover, Michael H. Pillinger	4
8	Gout and Metabolic Syndrome: a Tangled Web 2017 ·Current Rheumatology Reports ·(unknown), Svetlana Krasnokutsky, Michael H. Pillinger	114
9	Cardiovascular Disease Prevalence in Patients with Osteoarthritis, Gout, or Both. 2016 ·PubMed ·Dae-Hyouk Bang, Jinfeng Xu, Robert T. Keenan, (unknown), Ralf Lehmann, Craig Tenner, Daria B. Crittenden, Michael H. Pillinger, Svetlana Krasnokutsky	9
10	Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects 2015 ·Inflammation ·Binita Shah, Nicole Allen, (unknown), Michael H. Pillinger, Stuart D. Katz, Steven P. Sedlis, Christina Echagarruga, (unknown), (unknown), P. Singh, (unknown), Jeffrey S. Berger	65
11	Fellow use of medical jargon correlates inversely with patient and observer perceptions of professionalism: results of a rheumatology OSCE (ROSCE) using challenging patient scenarios 2015 ·Clinical Rheumatology ·Jessica Berman, (unknown), Anne R. Bass, Irene Blanco, Anne Davidson, Edward M. Dwyer, Theodore Fields, (unknown), (unknown), Leslie Dubin Kerr, (unknown), Deana Lazaro, (unknown), Stephen A. Paget, Michael H. Pillinger	15
12	Designing and Implementing INTREPID, an Intensive Program in Translational Research Methodologies for New Investigators 2014 ·Clinical and Translational Science ·Claudia S. Plottel, Yindalon Aphinyanaphongs, Yongzhao Shao, (unknown), Yixin Fang, Judith D. Goldberg, (unknown), (unknown), (unknown), Judith S. Hochman, Bruce N. Cronstein, Michael H. Pillinger	7
13	The causes of drug-induced muscle toxicity 2014 ·Current Opinion in Rheumatology ·Jonathan D. G. Jones, (unknown), Robert L. Wortmann, Michael H. Pillinger	19
14	Hyperuricemia, Gout, and Related Comorbidities: Cause and Effect on a Two-Way Street 2014 ·Southern Medical Journal ·(unknown), Daria B. Crittenden, Michael H. Pillinger	52
15	Advances in the management of gout: Critical appraisal of febuxostat in the control of hyperuricemia 2010 ·SHILAP Revista de lepidopterología ·Lada Beara‐Lasić, Michael H. Pillinger, David S. Goldfarb	4
16	Helicobacter pylori CagA Phosphorylation Status Determines the gp130-activated SHP2/ERK and JAK/STAT Signal Transduction Pathways in Gastric Epithelial Cells 2010 ·Journal of Biological Chemistry ·(unknown), Jie‐Hyun Kim, (unknown), Michael H. Pillinger, Seok-Yong Kim, Martin J. Blaser, Yong Chan Lee	108
17	Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor 2009 ·The Journal of Immunology ·(unknown), H. Al-Mussawir, (unknown), (unknown), (unknown), (unknown), Michael H. Pillinger, Steven B. Abramson	15
18	Annexin-1 Mediates TNF-α-Stimulated Matrix Metalloproteinase Secretion from Rheumatoid Arthritis Synovial Fibroblasts 2008 ·The Journal of Immunology ·Clément E. Tagoe, Nada Marjanović, Jean Y. Park, Edwin S. L. Chan, Aryeh M. Abeles, Mukundan Attur, Steven B. Abramson, Michael H. Pillinger	41
19	Cyclooxygenase-2-Derived E Prostaglandins Down-Regulate Matrix Metalloproteinase-1 Expression in Fibroblast-Like Synoviocytes via Inhibition of Extracellular Signal-Regulated Kinase Activation 2003 ·The Journal of Immunology ·Michael H. Pillinger, Perry Rosenthal, Sonia Tolani, Beth Apsel, (unknown), Jeffrey D. Greenberg, Edwin S. L. Chan, Paul Gomez, Steven B. Abramson	71
20	Regulation of Expression of Granulocyte-Macrophage Colony-Stimulating Factor in Human Bronchial Epithelial Cells: Roles of Protein Kinase C and Mitogen-Activated Protein Kinases 2000 ·The Journal of Immunology ·Joan Reibman, (unknown), (unknown), (unknown), (unknown), Diana Nilsen, Michael H. Pillinger	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact